$56.37
0.32[0.57%]
At close: Apr 22
$56.37
0[0.00%]
PreMarket: 5:58PM EDT
Latest News for Catalent Stock (NYSE:CTLT)
Catalent Stock (NYSE: CTLT)
Categories: All
Friday, April 12, 2024
Thursday, April 04, 2024
Tuesday, April 02, 2024
Friday, March 08, 2024
Thursday, March 07, 2024
- Novo Nordisk CFO Says If Catalent Deal Does Not Close, More Capex Will Be Needed To Build Fill-Finish Capacity InternallyBenzinga Newsdesk - Mar 7, 2024, 11:01AM
- Novo Nordisk CFO Says If Catalent Deal Does Not Close, Novo Will Also Do More Deals With Contract Drugmakers; Exec Says There Is Still Opportunity To Acquire Companies To Add To Its Obesity PipelineBenzinga Newsdesk - Mar 7, 2024, 10:47AM
Wednesday, March 06, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
Wednesday, February 28, 2024
Monday, February 26, 2024
Tuesday, February 20, 2024
Wednesday, February 14, 2024
- Catalent Says During 3 Months Ended Dec 31, 2023, Extends Restructuring Efforts To Reduce Costs, Headcount In Biologics & Pharma, Consumer Health Segments; Reduced Headcount By About 300 Employees, Incurred Cumulative Employee-Related Charges Of ~$12MBenzinga Newsdesk - Feb 14, 2024, 3:21PM
- Catalent Says Upon Termination Of Merger With Novo Nordisk's Parent Company, Catalent Could Be Required To Pay A Termination Fee Of About $345MBenzinga Newsdesk - Feb 14, 2024, 3:18PM
- Nearly Half Of S&P 500 Stocks Trade Below 50-Day Moving Average: Which One Is The Cheapest?Piero Cingari - Feb 14, 2024, 12:49PM
Monday, February 12, 2024
Friday, February 09, 2024
- Catalent Q2 Adjusted EPS $(0.24) May Not Be Comparable To $(0.02) Estimate, Sales $1.03B Beat $1.01B EstimateBenzinga Newsdesk - Feb 9, 2024, 8:04AM
- US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak MarchShanthi Rexaline - Feb 9, 2024, 7:32AM
- Earnings Scheduled For February 9, 2024Benzinga Insights - Feb 9, 2024, 4:55AM
Thursday, February 08, 2024
Wednesday, February 07, 2024
- Catalent's Bloomington Plant Making Novo Nordisk's Obesity Drug Faces FDA Scrutiny Regarding Drug Manufacturing ConcernsVandana Singh - Feb 7, 2024, 12:02PM
- European Drugs Regulator EMA Says It Will Assess The Impact On Availability Of Medicines Made At Catalent Sites That Were Sold To Novo NordiskBenzinga Newsdesk - Feb 7, 2024, 11:56AM
Tuesday, February 06, 2024
- Lilly Exec Says "Intend On Holding Catalent Accountable To Their Contract" As The Company Gains More Information On Novo-Catalent DealBenzinga Newsdesk - Feb 6, 2024, 11:16AM
- Catalent Analysts Raise Their Forecasts Following Acquisition NewsAvi Kapoor - Feb 6, 2024, 8:22AM
- Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For TuesdayAvi Kapoor - Feb 6, 2024, 7:54AM
- RBC Capital Downgrades Catalent to Sector Perform, Raises Price Target to $63.5Benzinga Newsdesk - Feb 6, 2024, 6:17AM
- UBS Downgrades Catalent to Neutral, Raises Price Target to $63.5Benzinga Newsdesk - Feb 6, 2024, 6:06AM
- Stephens & Co. Downgrades Catalent to Equal-Weight, Announces $63.5 Price TargetBenzinga Newsdesk - Feb 6, 2024, 5:53AM
Monday, February 05, 2024
- Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?Piero Cingari - Feb 5, 2024, 2:12PM
- Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Feb 5, 2024, 12:56PM
- What's Going On With Eli Lilly Stock Today?Vandana Singh - Feb 5, 2024, 11:58AM
- Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On MondayAvi Kapoor - Feb 5, 2024, 10:32AM
- Catalent shares are trading higher after the company announced it will be acquired by Novo Holdings.Benzinga Newsdesk - Feb 5, 2024, 9:12AM
- Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug DemandBenzinga Neuro - Feb 5, 2024, 8:40AM
- Novo Holdings to Acquire Catalent for $63.50/Share at a Valuation of $16.5BBenzinga Newsdesk - Feb 5, 2024, 6:02AM
Thursday, January 25, 2024
Friday, January 19, 2024
Tuesday, December 19, 2023
Friday, December 15, 2023
Thursday, November 30, 2023
Thursday, November 16, 2023
- RBC Capital Maintains Outperform on Catalent, Lowers Price Target to $55Benzinga Newsdesk - Nov 16, 2023, 11:02AM
- Wells Fargo Maintains Equal-Weight on Catalent, Lowers Price Target to $42Benzinga Newsdesk - Nov 16, 2023, 9:01AM
- Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For ThursdayLisa Levin - Nov 16, 2023, 8:07AM
- What 9 Analyst Ratings Have To Say About CatalentBenzinga Insights - Nov 16, 2023, 8:00AM
- Baird Upgrades Catalent to Outperform, Raises Price Target to $53Benzinga Newsdesk - Nov 16, 2023, 6:00AM